Eden Research (LON:EDEN) Stock Price Down 3.3% – Here’s Why

by · The Markets Daily

Shares of Eden Research plc (LON:EDEN – Get Free Report) fell 3.3% during mid-day trading on Saturday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares traded hands during trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Trading Down 3.3 %

The firm has a market capitalization of £18.56 million, a PE ratio of -12.19 and a beta of 0.92. The business has a 50 day moving average price of GBX 3.88 and a 200-day moving average price of GBX 3.95. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26.

Insider Transactions at Eden Research

In other news, insider Alexander John Abrey acquired 540,540 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The stock was purchased at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,317.25). Also, insider Lykele van der Broek acquired 256,000 shares of the company’s stock in a transaction that occurred on Thursday, February 6th. The stock was purchased at an average cost of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,937.46). Company insiders own 14.02% of the company’s stock.

Eden Research Company Profile

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.

Read More